Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Not a "fudster", just not a pumper
View:
Post by Stocktree on May 24, 2023 10:59am

Not a "fudster", just not a pumper

You think the role of a poster is to promote the stock. I think it is to discuss the pros and cons of an investment. And since you are always exagerating the potential of the stock on a volcanic scale, and without taking into consideration the history of the company, other posters need to balance your used needle salesman act.

In this case, it's easy.
10 patients over the last 132 days.
At this pace, the end of recruitment, not of trial, is August 2026.
Dead money until then.
And with app. 1 patient enrolled per site during a period of 4+ month period, the product is not showing promising to take over the sepsis market any time soon, so no revenues for a big while.
Also, where is the cash we were going to be buried in thanks to Dialco? Let's forget about that adventure altogether I guess.

And for longtime shareholders who are not pumping the stock this morning for day trading purposes, the stock is still at 32 cents, which is in the realm of what it has been for the past 20 years.
Volume today at 11:00 am: 0
Comment by mercedesman on May 24, 2023 11:40am
Wow  where do I start with this latest lame attempt at bashing? In this case, it's easy. 10 patients over the last 132 days. Or to use the most recent data, 7 since April. Disingenuous at best. Always use the latest data when extrapolating. At this pace, the end of recruitment, not of trial, is August 2026. A horrible & misleading extrapolation without considering recent events ...more  
Comment by Stocktree on May 24, 2023 11:43am
Never use the shortest most favourable period of time to extrapolate.
Comment by mercedesman on May 24, 2023 1:07pm
The trend is your friend ( particularly when measured from a fundamental change event - like say a new CRO appointment or Invesitgator Meeting ) ...but I suspect that you have no friends, and wouldn't know this. MM  
Comment by BayStreetWild on May 26, 2023 12:55pm
Which time period is this trend for 20 year or 5 year or 1 year? They're all more or less the same. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities